Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Romiplostim

Brand: Nplate®
NICE TA: 221
Indication: Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221)
Disease category: Nutrition and blood
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Romiplostim is recommended as an option for treating chronic immune (idiopathic) thrombocytopenic purpura in adults, only if:

• their condition is refractory to standard active treatments and rescue therapies or
• they have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies.

Romiplostim is recommended only if the company makes it available with the discount agreed in the patient access scheme.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA221 - Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red